Micot Pharma Presents MT200605 at World Stroke Congress
Micot Pharma presented its in-house neuroprotective drug candidate MT200605 at the 18th World Stroke Congress in Seoul on October 21–23, 2026.
Micot Pharma presented its in-house neuroprotective drug candidate MT200605 at the 18th World Stroke Congress in Seoul on October 21–23, 2026.